Cargando…
Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits
The high price of new generations of vaccines relative to their predecessors has become an important consideration in debates over whether the benefits of the new vaccines justify their costs. An increasingly central line of inquiry in the literature on valuing vaccination surrounds accounting for t...
Autores principales: | Stawasz, Andrew, Huang, Liping, Kirby, Paige, Bloom, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366491/ https://www.ncbi.nlm.nih.gov/pubmed/32754566 http://dx.doi.org/10.3389/fpubh.2020.00261 |
Ejemplares similares
-
The full benefits of adult pneumococcal vaccination: A systematic review
por: Cafiero-Fonseca, Elizabeth T., et al.
Publicado: (2017) -
2457. Multivariate Analyses of Socio-Economic Inequities in Parental Awareness and Utilization of Meningococcal Serogroup B Vaccines
por: Huang, Liping, et al.
Publicado: (2018) -
Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
por: Srivastava, Amit, et al.
Publicado: (2020) -
Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016) -
2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
por: Johnson, Reed, et al.
Publicado: (2020)